Author

Matthew C. Torhan

Observed name: Matthew Torhan

Institution: Microbiotix (United States)

Observed institution: Microbiotix (United States)

OpenAlex ID: A5076216598

Mutations in the Pseudomonas aeruginosa Needle Protein Gene pscF Confer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System

2014 · Nicholas O. Bowlin, John D. Williams, et al. · Antimicrobial Agents and Chemotherapy · 63

Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection

2017 · Bryan J. Berube, Katherine R. Murphy, et al. · Antimicrobial Agents and Chemotherapy · 53

trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo

2021 · Zachary D. Aron, Atousa Mehrani, et al. · Nature Communications · 48

Synthesis and structure–activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS)

2015 · John D. Williams, Matthew C. Torhan, et al. · Bioorganic & Medicinal Chemistry · 40

A comparison of N- versus O-alkylation of substituted 2-pyridones under Mitsunobu conditions

2013 · Matthew C. Torhan, Norton P. Peet, et al. · Tetrahedron Letters · 34

Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus

2022 · Andrea J. Parsons, Sabrina I. Ophir, et al. · Antiviral Research · 5

Ribosome rescue inhibitors clear Neisseria gonorrhoeae in vivo using a new mechanism

2020 · Zachary D. Aron, Atousa Mehrani, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Works count: 7

Citation count: 244

H-index: 5

I10-index: 5